Novonix (NVX) director Sharan Burrow reports new shareholdings

Rhea-AI Filing Summary

Novonix Limited, a foreign private issuer, reported an update to director Sharan Burrow’s holdings. An issue of shares under the company’s Share Purchase Plan changed her direct relevant interest, and she now holds 246,989 ordinary shares and 195,938 share rights. No changes were reported to any related contracts, and it was confirmed that the interests were not traded during a closed period requiring prior written clearance.

Key Figures

Ordinary shares held by director: 246,989 shares Share rights held by director: 195,938 share rights Commission File Number: 001-41208 +1 more

4 metrics

Ordinary shares held by director 246,989 shares Sharan Burrow's direct relevant interest after Share Purchase Plan issue

Share rights held by director 195,938 share rights Sharan Burrow's holdings after reported change

Commission File Number 001-41208 SEC registration reference for Novonix Limited

ABN 54 157 690 830 Australian Business Number of Novonix Limited

Key Terms

Share Purchase Plan, Appendix 3Y, relevant interests in securities, closed period

4 terms

Share Purchase Plan financial

"Nature of change ... Issue of shares under the Share Purchase Plan."

A share purchase plan is an offer that lets existing shareholders buy additional shares directly from a company, usually at a set price and often with lower fees than buying on the open market. Think of it like a limited-time group sale that raises cash for the company; it matters to investors because it can be a cheap way to increase holdings, but adding more shares can reduce each existing share's slice of ownership and influence the stock price.

Appendix 3Y regulatory

"Appendix 3Y Change of Director’s Interest Notice"

relevant interests in securities regulatory

"Part 1 - Change of director’s relevant interests in securities"

closed period regulatory

"traded during a + closed period where prior written clearance was required"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/24/2026 - 06:02 AM Accepted by SEC EDGAR 07/23/2026 - 06:23 PM Learn about SEC filing dates

FAQ

What director interest change did Novonix (NVX) disclose in this filing?

Novonix disclosed a change in director Sharan Burrow’s relevant interests. Following an issue of shares under the Share Purchase Plan, she now holds 246,989 ordinary shares and 195,938 share rights, as recorded in an Appendix 3Y Change of Director’s Interest Notice.

How many Novonix (NVX) ordinary shares does director Sharan Burrow now hold?

After the reported change, Sharan Burrow holds 246,989 ordinary shares in Novonix. This figure reflects her direct relevant interest following an issue of shares under the company’s Share Purchase Plan, as set out in the Appendix 3Y attached to the Form 6-K.

How many share rights in Novonix (NVX) does Sharan Burrow hold after the change?

Sharan Burrow now holds 195,938 share rights in Novonix. These share rights are reported as part of her direct relevant interests in securities, alongside her ordinary shares, in the Appendix 3Y Change of Director’s Interest Notice furnished with the Form 6-K.

What was the nature of the change in Sharan Burrow’s interests at Novonix (NVX)?

The change in Sharan Burrow’s interests arose from an issue of shares under the Share Purchase Plan. This transaction affected her direct relevant interest in Novonix securities and is detailed in the Appendix 3Y included as Exhibit 99.1 to the Form 6-K.

Did the Novonix (NVX) director trade during a closed period requiring clearance?

The notice states that the director’s interests were not traded during a closed period where prior written clearance was required. Accordingly, there was no need to obtain or report any prior written clearance related to trading in a closed period.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of July, 2026

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		ASX Announcement (Change of Director's Interest Notice) dated July 24, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:		/s/ Mike O'Kronley
		Mike O'Kronley
		Chief Executive Officer

Date: July 24, 2026

Exhibit 99.1

Appendix 3Y

Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NOVONIX LIMITED

ABN 54 157 690 830

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	SHARAN BURROW
Date of last notice	6 May 2026

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	22 July 2026
No. of securities held prior to change	215,739 Ordinary shares 195,938 share rights
Class	Ordinary shares
Number acquired	31,250 ordinary shares
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$5,000

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director’s Interest Notice

No. of securities held after change	246,989 Ordinary shares 195,938 share rights
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of shares under the Share Purchase Plan.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

Exhibit 99.1

Appendix 3Y

Change of Director’s Interest Notice

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 50.2 KB